128 related articles for article (PubMed ID: 12402899)
21. Current oral agents for type 2 diabetes. Many options, but which to choose when?
Ahmann AJ; Riddle MC
Postgrad Med; 2002 May; 111(5):32-4, 37-40, 43-6. PubMed ID: 12040862
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the pharmacologic management of diabetes mellitus.
Carlton FB
Emerg Med Clin North Am; 2000 Nov; 18(4):745-53. PubMed ID: 11130936
[TBL] [Abstract][Full Text] [Related]
23. Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al.
Yoshioka K; Yoshida T; Yoshikawa T
Diabetes Care; 2003 Dec; 26(12):3360-1; author reply 3361. PubMed ID: 14633838
[No Abstract] [Full Text] [Related]
24. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus.
Füchtenbusch M; Standl E; Schatz H
Exp Clin Endocrinol Diabetes; 2000; 108(3):151-63. PubMed ID: 10926309
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic management of diabetes mellitus.
Mozersky RP
J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
[TBL] [Abstract][Full Text] [Related]
26. Advances in oral therapy for type 2 diabetes.
Davis SN
Postgrad Med; 2000 May; 107(6 Suppl Key):16-20. PubMed ID: 19667506
[TBL] [Abstract][Full Text] [Related]
27. Type 2 diabetes management: a comprehensive clinical review of oral medications.
Quillen DM; Kuritzky L
Compr Ther; 2002; 28(1):50-61. PubMed ID: 11894443
[TBL] [Abstract][Full Text] [Related]
28. Post-load hyperglycaemia-an inappropriate therapeutic target.
Yudkin JS
Lancet; 2002 Jan; 359(9301):166-7. PubMed ID: 11809285
[No Abstract] [Full Text] [Related]
29. [New prospects for the type 2 diabetic patient. Delaying disease progression].
MMW Fortschr Med; 2000 Nov; 142(46):56-7. PubMed ID: 11138590
[No Abstract] [Full Text] [Related]
30. [Type 2 diabetes. Regulating insulin according to need].
MMW Fortschr Med; 2001 Oct; 143(42):62. PubMed ID: 11697294
[No Abstract] [Full Text] [Related]
31. Type 2 diabetes mellitus: a review of pharmacological treatment.
Siminialayi IM; Emem-Chioma PC
Niger J Med; 2006; 15(3):207-14. PubMed ID: 17111744
[TBL] [Abstract][Full Text] [Related]
32. Hypersensitivity to repaglinide.
Rojas P; Sánchez L; Santos A; Góõmez MP; Blanco H; Laguna JJ
J Investig Allergol Clin Immunol; 2011; 21(3):245-7. PubMed ID: 21548456
[TBL] [Abstract][Full Text] [Related]
33. [New molecules].
Sternon J
J Pharm Belg; 2001; 56(5):105-10. PubMed ID: 11759148
[TBL] [Abstract][Full Text] [Related]
34. Insulinotropic meglitinide analogues.
Dornhorst A
Lancet; 2001 Nov; 358(9294):1709-16. PubMed ID: 11728565
[TBL] [Abstract][Full Text] [Related]
35. [Sulfonylureas and glinides].
Kudo K; Hirose T
Nihon Rinsho; 2011 Jan; 69 Suppl 1():645-53. PubMed ID: 21766676
[No Abstract] [Full Text] [Related]
36. [New glucose regulator. More comfort for the type 2 diabetic patient].
MMW Fortschr Med; 2001 Feb; 143(6):57. PubMed ID: 11247371
[No Abstract] [Full Text] [Related]
37. Oral agents in managing diabetes mellitus in children and adolescents.
Jacobson-Dickman E; Levitsky L
Pediatr Clin North Am; 2005 Dec; 52(6):1689-703. PubMed ID: 16301089
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone.
Lawrence JM; Reckless JP
Int J Clin Pract; 2000 Nov; 54(9):614-8. PubMed ID: 11220991
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
Bressler R; Johnson DG
Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
[TBL] [Abstract][Full Text] [Related]
40. Nateglinide for type 2 diabetes.
Med Lett Drugs Ther; 2001 Apr; 43(1101):29-30. PubMed ID: 11283474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
